Ind-Swift Laboratories Limited (BOM:532305)
India · Delayed Price · Currency is INR 143.75
+11.65 (8.82%)
At close: Apr 21, 2026
Ind-Swift Laboratories Market Cap
Ind-Swift Laboratories has a market cap or net worth of 12.35 billion as of April 22, 2026. Its market cap has increased by 143.87% in one year.
Market Cap
12.35B
Enterprise Value
8.37B
Revenue
5.94B
Ranking
n/a
PE Ratio
4.97
Stock Price
143.75
Market Cap Chart
Since June 1, 1999, Ind-Swift Laboratories's market cap has increased from 111.51M to 12.35B, an increase of 10,971.26%. That is a compound annual growth rate of 19.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 12.48B | 73.49% |
| Dec 31, 2025 | 7.19B | 12.14% |
| Dec 31, 2024 | 6.42B | 4.85% |
| Dec 29, 2023 | 6.12B | 49.10% |
| Dec 30, 2022 | 4.10B | 2.21% |
| Dec 31, 2021 | 4.01B | 9.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suven Life Sciences | 51.66B |
| Gujarat Themis Biosyn | 34.81B |
| IOL Chemicals and Pharmaceuticals | 26.76B |
| Sai Parenteral's | 21.21B |
| NGL Fine-Chem | 13.78B |
| Bajaj HealthCare | 11.02B |
| Anlon Healthcare | 7.54B |
| Shree Ganesh Remedies | 6.85B |